Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06407986
Other study ID # '2023-933-01'
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 15, 2024
Est. completion date December 31, 2024

Study information

Verified date May 2024
Source Sir Run Run Shaw Hospital
Contact Jiayi Li
Phone 17326082419
Email 22218299@zju.edu.cn
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

To evaluate the demographic characteristics of normal one-second rates population in patients with pulmonary function tests recommended by outpatient physicians. To investigate whether EIT can identify spatial and temporal heterogeneity of lung ventilation in individuals with normal one-second rates during pulmonary function testing. To investigate the distribution patterns of lung ventilation in individuals with normal one-second rates using this technique, and provide references and evidence for early screening, diagnosis, treatment monitoring, and prognostic evaluation.


Description:

In the GOLD 2023 guidelines, a newly introduced term called "Preserved Ratio Impaired Spirometry (PRISm)" refers to patients who have a normal forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) ratio (FEV1/FVC≥0.7, after bronchodilator use), but exhibit impaired pulmonary ventilation function with FEV1 and/or FVC values below 80% of the predicted value. In the past, these patients were often classified as GOLD U or restrictive ventilatory impairment. In recent years, several large cross-sectional and longitudinal studies on PRISm have revealed its high prevalence, ranging from 5-20% due to population heterogeneity. Notably, approximately 10% to 40% of patients with PRISm tend to develop chronic obstructive pulmonary disease (COPD), resulting in frequent healthcare utilization. Moreover, subjects with normal lung function are also at risk of converting to PRISm during long-term follow-up. Studies have found that such patients are associated with increased respiratory symptoms, reduced quality of life, and increased burden of cardiovascular disease. A recent meta-analysis showed a significant increased risk of all-cause, cardiovascular, and respiratory-related mortality risk in PRISm patients. Currently, there are no diagnostic and treatment guidelines for PRISm, but studies highlights the importance of screening and identifying PRISm, with follow-up and early intervention if necessary. Electrical Impedance Tomography (EIT) is an emerging imaging technology developing rapidly in recent years, with many advantages such as non-invasive, non-radiation and simple operation. Its principle is to measure the voltage or current signals through electrodes on the body surface, and then reconstructing images of the distribution of impedance changes. This technology is widely used in pulmonary diseases, including monitoring lung ventilation distribution, blood perfusion, and titration of positive end-expiratory pressure. EIT images have high spatial and temporal resolution, can display physiological and pathological changes in real time based on breathing. In 2022, China issued the clinical application consensus of electrical impedance tomography in critical respiratory management, further promoting the application of this technology in respiratory management. However, the number of clinical studies on EIT in identifying airway obstruction in COPD patients is limited. It has been proven that in COPD patients, EIT combined with pulmonary function tests can evaluate the spatial and temporal distribution of lung capacity in different regions and identify pathologically induced ventilation heterogeneity. At present, the pathophysiological mechanism of PRISm is still under discussion. Studies have found that PRISm is related to small airway dysfunction (SAD) and decreased total lung capacity. Computed Tomography (CT) can be used to evaluate small airway function and observe the morphological and structural changes of lung tissue, but it has but it has some disadvantages such as long duration and radiation exposure. Therefore, EIT may be a good choice for rapidly assessing regional lung function in PRISm patients. Due to the scarcity of EIT in PRISm studies, investigators have initiated a clinical study to evaluate whether ventilation heterogeneity in PRISm patients can be obtained through the combination of EIT and pulmonary function tests.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date December 31, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: Age =18 years old. Patients who need to complete lung function tests assessed by outpatient physicians. Patients willing to participate in the study and sign an informed consent form. Exclusion Criteria: Patients with FEV1/FVC less than 0.7 after a bronchiectasis test. Patients with a history of lung diseases other than COPD, previous lung surgery, or radiation therapy. Patients who cannot be evaluated for EIT or who interfere with EIT results, such as implanted pacemakers/cardioverters. Patients who cannot complete EIT or may interfere with EIT results, such as those with implanted pacemakers/defibrillators. Patients who cannot complete lung function tests, such as myocardial infarction or shock in the past 3 months; severe heart failure or angina in the past 4 weeks,uncontrolled hypertension (systolic >200mmHg, diastolic >100mmHg),severe hyperthyroidism etc. Vulnerable populations, including patients with mental illnesses, cognitive impairments, critically ill patients, illiterate, pregnant women, etc.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
pulmonary function test
Whether the estimated value of FEV1 and FVC is greater than 80%.

Locations

Country Name City State
China Sir Run Run Shaw Hospital Hangzhou Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
Sir Run Run Shaw Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary regional FEV1 They were calculated for each pixel within the lung areas by EIT data analysis one month
Primary regional FVC They were calculated for each pixel within the lung areas by EIT data analysis one month
Secondary St. George's Respiratory Questionnaire Score change,the higher the score, the more severe the symptoms one month
Secondary regional obstructive ratio(rOR) It was calculated based on the size of obstructed regions in related to the entire lung area. one month
See also
  Status Clinical Trial Phase
Completed NCT03850977 - Is There an Association Between Chronic Pancreatitis and Pulmonary Function
Completed NCT06421168 - Lung Function in Bariatric Surgery Candidates
Completed NCT05085795 - Evaluating Deep Breathing in Health Participants Using a Device Called Impulse Oscillometry
Enrolling by invitation NCT05339048 - The Cartagena Cohort Study
Enrolling by invitation NCT05724082 - The Effect of Household Air Pollution on Lung Function Growth in Infants With Pneumonia in Sub-Saharan Africa N/A
Active, not recruiting NCT04535154 - Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19
Recruiting NCT03471884 - Effects of Nonintubated Thoracoscopic Lobectomy on Lung Protection N/A
Completed NCT03052491 - Effects of a 10 Component Dietary Supplement on Health and the Quality of Life N/A
Completed NCT04171583 - Mucoid Staphylococcus Aureus in Cystic Fibrosis Airways
Active, not recruiting NCT05246930 - Evaluating the Use of a Device Called Impulse Oscillometry in Participants With Vocal Cord Disorders or Asthma
Recruiting NCT03551197 - Change of Lung Function After Exercise in Patients With Chronic Obstructive Pulmonary Disease Phase 4
Completed NCT05857475 - Efficacy of CPAP Therapy on Pulmonary Function Test in Patients With COPD-OSA Overlap Syndrome N/A
Completed NCT03054675 - Perioperative Lung Function Monitoring After Anatomic Lung Resections N/A
Completed NCT05008991 - Lung Functions in Menopausal Obese Women After COVID 19 Recovery
Completed NCT05348759 - Pulmonary Function and CT Scan Finding in CKD Patients After COVID-19 Infection
Completed NCT04863027 - Use of Dual Energy Computed Tomography in Thoracic Radiotherapy Planning.
Completed NCT04122547 - Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis Phase 3
Completed NCT06070584 - Effect of Respiratory Muscle Training on Lung Function on Quarry Workers in Minia Government Egypt Phase 1
Completed NCT04868240 - Concurrent Training and Metabolic Profile, Lung Function, Quality of Life and Stress N/A
Completed NCT05216549 - Water and Land-based Exercise for Children With Post COVID-19 Condition N/A